StockData
Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc. (XENE) KPIs and segments

XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$39.26−1.22 (-3.01%)

Close on Nov 16, 2026Market cap $3.80BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Xenon Pharmaceuticals's business

Coming soon

This tab will track the numbers specific to Xenon Pharmaceuticals's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?